Adicet Bio, Inc. (ACET) Insider Trading
Directors, officers and holders of more than 10% of ACET report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 49 most recent of 49 transactions on file: 5 with code P, 4 with code S and 40 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Klickstein Lloyd | Chief Medical Officer | A Award | 18,300 | Not measured | Not measured |
| Jun 21, 2026 | Klickstein Lloyd | Chief Medical Officer | A Award | 4,200 | Not measured | Not measured |
| Jun 21, 2026 | Sinclair Andrew | Director | A Award | 4,200 | Not measured | Not measured |
| Jun 21, 2026 | Grissinger Michael | Director | A Award | 4,200 | Not measured | Not measured |
| Jun 21, 2026 | Peng Katie | Director | A Award | 4,200 | Not measured | Not measured |
| Jun 21, 2026 | DUBIN STEVE | Director | A Award | 4,200 | Not measured | Not measured |
| Jun 21, 2026 | Chodakewitz Jeffrey | Director | A Award | 4,200 | Not measured | Not measured |
| Jun 19, 2026 | Schor Chen | President & CEO | A Award | 55,000 | Not measured | Not measured |
| Jun 19, 2026 | Aftab Blake | Chief Scientific Officer | A Award | 55,000 | Not measured | Not measured |
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | J Other | 250,000 | Not measured | Not measured |
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | J Other | 250,000 | Not measured | Not measured |
| Apr 8, 2026 | ORBIMED ADVISORS LLC | 10% Owner | S Sale | 32,523 | $6.29 | $204,570 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC | 10% Owner | S Sale | 40,416 | $6.52 | $263,512 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC | 10% Owner | S Sale | 29,319 | $6.53 | $191,453 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2,400 | $6.38 | $15,312 |
| Mar 25, 2026 | Aftab Blake | Chief Scientific Officer | A Award | 72,555 | Not measured | Not measured |
| Mar 25, 2026 | Schor Chen | President & CEO | A Award | 468,555 | Not measured | Not measured |
| Mar 25, 2026 | Harvey Brian Nicholas | Chief Financial Officer | A Award | 43,361 | Not measured | Not measured |
| Mar 25, 2026 | Healey Don | Chief Technology Officer | A Award | 43,361 | Not measured | Not measured |
| Mar 25, 2026 | Maltzman Julia D. | Chief Medical Officer | A Award | 72,555 | Not measured | Not measured |
| Feb 20, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | P Purchase | 74,751 | $7.27 | $543,440 |
| Feb 19, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | P Purchase | 74,268 | $7.21 | $535,472 |
| Feb 18, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | P Purchase | 74,577 | $7.04 | $525,022 |
| Jan 24, 2026 | Harvey Brian Nicholas | Chief Financial Officer | F Tax Payment | 546 | $8.44 | $4,608 |
| Jan 24, 2026 | Aftab Blake | Chief Scientific Officer | F Tax Payment | 535 | $8.44 | $4,515 |
| Jan 24, 2026 | Healey Don | Chief Technology Officer | F Tax Payment | 535 | $8.44 | $4,515 |
| Jan 24, 2026 | Schor Chen | President & CEO | F Tax Payment | 1,755 | $8.44 | $14,812 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC | 10% Owner | P Purchase | 218,750 | $16.00 | $3,500,000 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC | 10% Owner | P Purchase | 93,750 | $16.00 | $1,500,000 |
| Jun 11, 2025 | Chodakewitz Jeffrey | Director | A Award | 26,400 | Not measured | Not measured |
| Jun 11, 2025 | Klickstein Lloyd | Chief Medical Officer | A Award | 26,400 | Not measured | Not measured |
| Jun 11, 2025 | Sinclair Andrew | Director | A Award | 369 | Not measured | Not measured |
| Jun 11, 2025 | Peng Katie | Director | A Award | 369 | Not measured | Not measured |
| Jun 11, 2025 | DUBIN STEVE | Director | A Award | 369 | Not measured | Not measured |
| Jun 11, 2025 | Chodakewitz Jeffrey | Director | A Award | 369 | Not measured | Not measured |
| Jun 11, 2025 | Peng Katie | Director | A Award | 26,400 | Not measured | Not measured |
| Jun 11, 2025 | Klickstein Lloyd | Chief Medical Officer | A Award | 369 | Not measured | Not measured |
| Jun 11, 2025 | DUBIN STEVE | Director | A Award | 26,400 | Not measured | Not measured |
| Jun 11, 2025 | Sinclair Andrew | Director | A Award | 26,400 | Not measured | Not measured |
| Apr 17, 2025 | Grissinger Michael | Director | A Award | 70,200 | Not measured | Not measured |
| Jan 31, 2025 | Maltzman Julia D. | Chief Medical Officer | A Award | 750,000 | Not measured | Not measured |
| Jan 31, 2025 | Healey Don | Chief Technology Officer | A Award | 275,000 | Not measured | Not measured |
| Jan 31, 2025 | Aftab Blake | Chief Scientific Officer | A Award | 275,000 | Not measured | Not measured |
| Jan 31, 2025 | Schor Chen | President & CEO | A Award | 763,829 | Not measured | Not measured |
| Jan 31, 2025 | Harvey Brian Nicholas | Chief Financial Officer | A Award | 324,040 | Not measured | Not measured |
| Jan 24, 2025 | Healey Don | Chief Technology Officer | F Tax Payment | 535 | $14.75 | $7,891 |
| Jan 24, 2025 | Aftab Blake | Chief Scientific Officer | F Tax Payment | 392 | $14.75 | $5,780 |
| Jan 24, 2025 | Harvey Brian Nicholas | Chief Financial Officer | F Tax Payment | 547 | $14.75 | $8,068 |
| Jan 24, 2025 | Schor Chen | President & CEO | F Tax Payment | 1,756 | $14.75 | $25,904 |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.